Offer - Urjas Oil for just ₹ 1 X
Ebastine + Montelukast is an allopathic medicine The correct dosage of Ebastine + Montelukast depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Ebastine + Montelukast is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Ebastine + Montelukast is used -
Severe
Moderate
Mild
Common
Unknown
Is the use of Ebastine + Montelukast safe for pregnant women?
Pregnant women may experience moderate side effects from Ebastine + Montelukast. It is best to stop taking Ebastine + Montelukast immediately and inform your doctor if you notice any discomfort.
Is the use of Ebastine + Montelukast safe during breastfeeding?
Ebastine + Montelukast may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Ebastine + Montelukast, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Ebastine + Montelukast.
What is the effect of Ebastine + Montelukast on the Kidneys?
Very few cases of side effects of Ebastine + Montelukast on kidney have been reported.
What is the effect of Ebastine + Montelukast on the Liver?
Ebastine + Montelukast can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Ebastine + Montelukast on the Heart?
Ebastine + Montelukast has very mild side effects on the heart.
Ebastine + Montelukast should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ebastine + Montelukast unless your doctor advises you to do so -
Is this Ebastine + Montelukast habit forming or addictive?
Ebastine + Montelukast does not cause addiction.
Interaction between Food and Ebastine + Montelukast
There isn't any research available on the side effects of taking Ebastine + Montelukast with food.
Interaction between Alcohol and Ebastine + Montelukast
Consuming Ebastine + Montelukast with alcohol can have many serious effects on your body.
Yes, you can take Ebastine + Montelukast for skin allergy (skin reaction). Ebastine + Montelukast suppresses the histamine which causes skin allergy. Clinical studies suggest that this drug is safe and effective in treating a skin allergy. Since it is a prescription drug, you are advised not to take Ebastine + Montelukast by yourself without a doctor's recommendation.
Yes, you can take Ebastine + Montelukast for a common cold in combination with pseudoephedrine. It has been found to be safe and effective in providing relief from the symptoms of common cold.
Ebastine + Montelukast is a brand name of ebastine and it is available in the form of tablet and suspension. It belongs to the class of drug known as antihistamines (H1 receptor antagonists). It is a prescription drug which is used to relieve allergic symptoms of hay fever (allergic rhinitis), and urticaria.
No. Ebastine + Montelukast is not a steroid. It belongs to the class of drug known as antihistamines (H1 receptor antagonists) which are used to provide relief from symptoms of allergies.
Yes, you can take Ebastine + Montelukast for IBS (Irritable bowel syndrome) only on your doctor's advice. Scientific suggest that this drug is helpful in reducing the symptoms of IBS.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 167
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)